Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
BioSpace
Wednesday, July 30, 2014 - 9:07am
tags:
Allergan, layoffs
Boston Scientific Wins First Vaginal-Mesh Injury Trial
Bloomberg
Wednesday, July 30, 2014 - 9:03am
tags:
Boston Scientific, vaginal mesh, devices
Hospira beats profit estimates, raises 2014 outlook
Yahoo/Reuters
Wednesday, July 30, 2014 - 9:02am
tags:
earnings, Hospira
Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials
Yahoo/Reuters
Wednesday, July 30, 2014 - 9:02am
tags:
cholesterol, Sanofi, Regeneron, alirocumab
Bayer Earnings Rise as New Drugs Offset Stronger Euro
Bloomberg
Wednesday, July 30, 2014 - 8:52am
tags:
Bayer, earnings
AstraZeneca buys Almirall lung drugs for up to $2.1 billion
Yahoo/Reuters
Wednesday, July 30, 2014 - 8:51am
tags:
M&A, AstraZeneca, Almirall, respiratory health
Is FDA ‘Buried’ Under a Backlog of Generic Drug Applications?
WSJ Online
Wednesday, July 30, 2014 - 8:50am
tags:
FDA, generics
Pfizer to buy Baxter’s vaccines for $635 million
Marketwatch
Wednesday, July 30, 2014 - 8:50am
tags:
Pfizer, Baxter International, vaccines, M&A
Vertex Pharma posts bigger 2Q loss
Yahoo/AP
Tuesday, July 29, 2014 - 7:36pm
tags:
Vertex Pharmaceuticals, earnings
FDA OKs expanded use of Regeneron's eye drug
Yahoo/Reuters
Tuesday, July 29, 2014 - 7:35pm
tags:
FDA, Regeneron, Eylea, diabetic macular edema
Pfizer leaves investors guessing on intentions for Astra
Yahoo/Reuters
Tuesday, July 29, 2014 - 7:34pm
tags:
Pfizer, M&A, AstraZeneca
Pfizer CEO says company "aggressively" seeking deals, does not rule out possible tax inversion
First Word Pharma
Tuesday, July 29, 2014 - 5:22pm
tags:
Ian Read, Pfizer, M&A, tax inversions, Pharma CEOs
Amgen 2nd quarter profit rises; announces up to 2,900 job cuts
Yahoo/AP
Tuesday, July 29, 2014 - 4:39pm
tags:
Amgen, earnings, layoffs
Don't get too excited, investors: GSK has no near-term plans for consumer health spinoff
Fierce Pharma
Tuesday, July 29, 2014 - 3:36pm
tags:
GSK, consumer health
Ranbaxy Reports Quarterly Loss on Settlement Provision
Bloomberg
Tuesday, July 29, 2014 - 3:35pm
tags:
Ranbaxy, earnings
Medical Devices and Technology take Wearables to a Whole New Level
Verix.com
Tuesday, July 29, 2014 - 3:34pm
tags:
Google, Apple, Novartis, devices, Wearable Medical Devices Market
Pfizer, Lilly and J&J chip in on $51M seed fund for New York biotechs
Fierce Biotech
Tuesday, July 29, 2014 - 2:33pm
tags:
JNJ, Eli Lilly, Pfizer, biotech
Beyond the Q2 numbers, three big questions for Pfizer
Fierce Pharma
Tuesday, July 29, 2014 - 2:30pm
tags:
Pfizer, R&D, earnings
Merck: No Tax Inversions, We Just Want Bolt-On Deals
WSJ Online
Tuesday, July 29, 2014 - 2:26pm
tags:
Merck, tax inversions, M&A
Galectin Drug is a Fatty Liver Flop
TheStreet.com
Tuesday, July 29, 2014 - 2:20pm
tags:
Galectin, GR-MD-02, non-alcoholic fatty liver disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.